clinical trial

Mark Thomas appointed as Head of Clinical Operations

Oxford Vacmedix UK Ltd announces the appointment of Mark Thomas as Head of Clinical Operations, bringing in-depth expertise in running clinical trials and in pharmaceutical development to Oxford Vacmedix. Press Release – appointment of Mark Thomas as Head of Clinical Operations Oxford, 14th June 2021: Oxford Vacmedix, the UK-based biopharma company focused on the development of cancer vaccines announced today the appointment of Mark Thomas as the Head of Clinical Operations. He was previou...
Read More
en_GBEnglish